FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016585612> ?p ?o ?g. }

• W2016585612 endingPage "567" @default.
• W2016585612 startingPage "562" @default.
• W2016585612 abstract "Drug resistance has been associated with resistance to NK- and LAK-cell-mediated cytotoxicity. We evaluated this issue in human cell lines, using multiple myeloma cells (8226) and 2 multi-drug-resistant (MDR) sublines selected using doxorubicin (8226/Dox40) and mitoxantrone (8226/MR40). In parallel, we studied the human breast carcinoma cell line series MCF7, MCF7/D40 and MCF7/Mitox. Unlike the sensitive parental cell lines, all 4 sublines display MDR-patterns of resistance, with the P-glycoprotein pump (P-170) detected only in the doxorubicin-selected sublines. Flow cytometric and immunocytochemical analyses showed expression of cellular adhesion molecules ICAM-1 and LFA-3, and MHC-Class-1 (MCF7/D40 only), to be decreased in the doxorubicin-selected MDR-sublines, whereas expression of CD56 (Leu 19) was strongly up-regulated in 8226/Dox40. Lysis of P-170-positive MDR tumor cells by NK or LAK cells was, however, unaffected by these alterations, suggesting redundancy in effector: target-cell adhesion pathways. Mitoxantrone-selected tumor cells did not display P-170, nor did they show altered expression of cellular adhesion molecules. Their susceptibility to NK or LAK cytolysis was also unimpaired as compared to the parental cell lines. Clinically, these results imply that immunotherapeutic modalities aiming at increased natural killer functions deserve full consideration even in patients who have become refractory to further cytostatic drug treatment." @default.
• W2016585612 created "2016-06-24" @default.
• W2016585612 creator A5009915233 @default.
• W2016585612 creator A5036944598 @default.
• W2016585612 creator A5056492087 @default.
• W2016585612 creator A5065474674 @default.
• W2016585612 creator A5071127912 @default.
• W2016585612 creator A5072898775 @default.
• W2016585612 creator A5073872908 @default.
• W2016585612 creator A5085426388 @default.
• W2016585612 date "1991-06-19" @default.
• W2016585612 modified "2023-09-24" @default.
• W2016585612 title "Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity" @default.
• W2016585612 cites W1524905787 @default.
• W2016585612 cites W1532556593 @default.
• W2016585612 cites W1750480583 @default.
• W2016585612 cites W1980379317 @default.
• W2016585612 cites W1995189245 @default.
• W2016585612 cites W2005426453 @default.
• W2016585612 cites W2005877531 @default.
• W2016585612 cites W2007931369 @default.
• W2016585612 cites W2026392633 @default.
• W2016585612 cites W2055323476 @default.
• W2016585612 cites W2071573211 @default.
• W2016585612 cites W2108117103 @default.
• W2016585612 cites W2140330341 @default.
• W2016585612 cites W2155697017 @default.
• W2016585612 cites W2161663775 @default.
• W2016585612 cites W2163636540 @default.
• W2016585612 cites W2164606734 @default.
• W2016585612 cites W2272221901 @default.
• W2016585612 cites W4234088346 @default.
• W2016585612 doi "https://doi.org/10.1002/ijc.2910480414" @default.
• W2016585612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1710609" @default.
• W2016585612 hasPublicationYear "1991" @default.
• W2016585612 type Work @default.
• W2016585612 sameAs 2016585612 @default.
• W2016585612 citedByCount "21" @default.
• W2016585612 countsByYear W20165856122018 @default.
• W2016585612 crossrefType "journal-article" @default.
• W2016585612 hasAuthorship W2016585612A5009915233 @default.
• W2016585612 hasAuthorship W2016585612A5036944598 @default.
• W2016585612 hasAuthorship W2016585612A5056492087 @default.
• W2016585612 hasAuthorship W2016585612A5065474674 @default.
• W2016585612 hasAuthorship W2016585612A5071127912 @default.
• W2016585612 hasAuthorship W2016585612A5072898775 @default.
• W2016585612 hasAuthorship W2016585612A5073872908 @default.
• W2016585612 hasAuthorship W2016585612A5085426388 @default.
• W2016585612 hasConcept C109316439 @default.
• W2016585612 hasConcept C114851261 @default.
• W2016585612 hasConcept C122871604 @default.
• W2016585612 hasConcept C129374314 @default.
• W2016585612 hasConcept C133936738 @default.
• W2016585612 hasConcept C1491633281 @default.
• W2016585612 hasConcept C154317977 @default.
• W2016585612 hasConcept C16224149 @default.
• W2016585612 hasConcept C202751555 @default.
• W2016585612 hasConcept C203014093 @default.
• W2016585612 hasConcept C2776694085 @default.
• W2016585612 hasConcept C2778102761 @default.
• W2016585612 hasConcept C2778707650 @default.
• W2016585612 hasConcept C2780923524 @default.
• W2016585612 hasConcept C2781303535 @default.
• W2016585612 hasConcept C28651165 @default.
• W2016585612 hasConcept C502942594 @default.
• W2016585612 hasConcept C54355233 @default.
• W2016585612 hasConcept C55493867 @default.
• W2016585612 hasConcept C73588182 @default.
• W2016585612 hasConcept C81885089 @default.
• W2016585612 hasConcept C85789140 @default.
• W2016585612 hasConcept C86803240 @default.
• W2016585612 hasConcept C89423630 @default.
• W2016585612 hasConceptScore W2016585612C109316439 @default.
• W2016585612 hasConceptScore W2016585612C114851261 @default.
• W2016585612 hasConceptScore W2016585612C122871604 @default.
• W2016585612 hasConceptScore W2016585612C129374314 @default.
• W2016585612 hasConceptScore W2016585612C133936738 @default.
• W2016585612 hasConceptScore W2016585612C1491633281 @default.
• W2016585612 hasConceptScore W2016585612C154317977 @default.
• W2016585612 hasConceptScore W2016585612C16224149 @default.
• W2016585612 hasConceptScore W2016585612C202751555 @default.
• W2016585612 hasConceptScore W2016585612C203014093 @default.
• W2016585612 hasConceptScore W2016585612C2776694085 @default.
• W2016585612 hasConceptScore W2016585612C2778102761 @default.
• W2016585612 hasConceptScore W2016585612C2778707650 @default.
• W2016585612 hasConceptScore W2016585612C2780923524 @default.
• W2016585612 hasConceptScore W2016585612C2781303535 @default.
• W2016585612 hasConceptScore W2016585612C28651165 @default.
• W2016585612 hasConceptScore W2016585612C502942594 @default.
• W2016585612 hasConceptScore W2016585612C54355233 @default.
• W2016585612 hasConceptScore W2016585612C55493867 @default.
• W2016585612 hasConceptScore W2016585612C73588182 @default.
• W2016585612 hasConceptScore W2016585612C81885089 @default.
• W2016585612 hasConceptScore W2016585612C85789140 @default.
• W2016585612 hasConceptScore W2016585612C86803240 @default.
• W2016585612 hasConceptScore W2016585612C89423630 @default.
• W2016585612 hasIssue "4" @default.
• W2016585612 hasLocation W20165856121 @default.

• next